Volume 16, Number 2—February 2010
Research
Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies1
Figure 1
![Schematic of hybrid transmission and decision analytic economic model. [+] indicates a cloned subtree with the same structure as the branch above. In sensitivity analysis, the probabilities of healthcare utilization and death were independent of each other but dependent on the probability of clinical infection. We assumed those with serious complications would seek primary healthcare. SEIR, susceptible, exposed, infected, removed.](/eid/images/09-0571-F1.jpg)
Figure 1. Schematic of hybrid transmission and decision analytic economic model. [+] indicates a cloned subtree with the same structure as the branch above. In sensitivity analysis, the probabilities of healthcare utilization and death were independent of each other but dependent on the probability of clinical infection. We assumed those with serious complications would seek primary healthcare. SEIR, susceptible, exposed, infected, removed.
1This material was compiled before the declaration of pandemic (H1N1) 2009 and concerns stockpiling for a future influenza pandemic.
Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.